merck glp 1 pays $112M upfront for Hansoh's preclinical GLP-1 Is $112m really that cheap
Description
About this research This Pew Research Center analysis explores obesity in the United States and Americans views of weight loss drugs known as GLP-1s (glucagon-like peptide-1 receptor agonists)
The receptor agonist is injected twice a day, whereas the Glp-1 analog requires only one injection per day

And even the sale, customer outreach and customer support are handled by AI

Research shows that stopping medication can cause you to regain much of the weight that was lost
The pharmacy visit becomes an incidental part of the trip rather than the sole purpose, which makes the economics work regardless of distance

[DOI] [PubMed] [Google Scholar] 191.Hansen L., Deacon C.F., Orskov C., Holst J.J
